Lung Cancer Diagnosis and Management in the Era of Precision Medicine

Explore the evolving landscape of lung cancer diagnosis and treatment through this comprehensive webinar presented by Dr. Jose Torrealba, a distinguished pathology professor at the University of Texas Southwestern. Gain insights into how precision medicine has transformed the approach to lung cancer management, moving beyond traditional tissue biopsy methods to incorporate advanced molecular profiling and clinical staging. Learn about the expanded molecular testing protocols that now include not only traditional markers like EGFR, ALK, and ROS1, but also newer targets enabled by Next Generation Sequencing and liquid biopsies. Discover how these technological advances have opened doors to targeted therapies and immunotherapies, particularly those targeting the PD-1/PD-L1 pathway. Understand the current methodologies for tissue acquisition and biopsy guidelines that support optimal patient care. Examine the integration of pathologic findings with molecular data to guide treatment decisions for both early-stage surgical candidates and patients with metastatic or advanced disease. Review the recommended molecular testing protocols and learn how these precision medicine approaches are improving outcomes for lung cancer patients, the leading cause of cancer-related deaths in the United States.